SCHEMBL3737087

SCHEMBL3737087

CON=C(C(N)=O)c1csc(N)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
ALDH1A1 P00352 2/20 0.48
MEN1 O00255 1/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 1/20 0.48
NR1I2 O75469 4/20 0.46
PGR P06401 1/20 0.46
PTGS2 P35354 1/20 0.46
LMNA P02545 2/20 0.46
GAA P10253 1/20 0.46
ITGB1 P05556 2/20 0.44
ITGA4 P13612 2/20 0.44
HTR2C P28335 1/20 0.42
ALB P02768 1/20 0.41
PPARG P37231 1/20 0.41
SLC22A6 Q4U2R8 1/20 0.41
SLC22A8 Q8TCC7 1/20 0.41
SLC22A11 Q9NSA0 1/20 0.41
TDP1 Q9NUW8 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8120449 1.00 MAPT (0.48) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL19236061 1.00 MAPT (0.48) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL14074009 0.88 MAPT (0.49) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL968131 0.88 MAPT (0.59) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL10263157 0.88 MAPT (0.49) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL5694533 0.88 MAPT (0.59) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL3929244 0.88 MAPT (0.48) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL968132 0.88 MAPT (0.59) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL9982497 0.88 MAPT (0.48) MAPTALDH1A1MEN1NPC1RAB9A
SCHEMBL3736579 0.86 MAPT (0.47) MAPTALDH1A1MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0111281-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-06-06 EP claimed
EP-0103264-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-12-20 EP claimed
EP-0109683-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-10-11 EP claimed
EP-0250096-A1 Isoxazolone derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-12-23 EP claimed
US-4584290-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1986-04-22 US claimed
US-4546101-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-10-08 US claimed
EP-0111281-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-06-20 EP claimed
EP-0109683-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-05-30 EP claimed
EP-0103264-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-03-21 EP claimed
JP-60252473-A None JP disclosed
JP-60248691-A None JP disclosed
JP-61072788-A None JP disclosed
US-7825238-B2 Antiviral methods employing double esters of 2′, 3′-dideoxy-3′-fluoroguanosine MEDIVIR AB (SE) 2010-11-02 US disclosed
WO-2008010042-A2 IMPROVED PROCESS FOR THE PREPARATION OF CEFEPIME INTERMEDIATE ORCHID CHEMICALS & PHARMACEUTICALS LIMITED (IN) 2008-01-24 WO disclosed
US-4291031-A 3-Phosphonocephalosporanic acid derivatives, and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-09-22 US disclosed
US-4264597-A FUNGICIDES FUJISAWA PHARMACEUTICAL CO., LTD., NO. 3, 4-CHOME, DOSHOMACHI, HIGASHI-KU, OSAKA, JAPAN 1981-04-28 US disclosed
US-4252951-A Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid ELI LILLY AND COMPANY (US) 1981-02-24 US disclosed
EP-0010313-A1 3,7-Disubstituted-2- or -3-cephem-4-carboxylic acid compounds, pharmaceutical compositions containing them and processes for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-04-30 EP disclosed
US-4200745-A 7[2-(2-Aminothiazol-4-yl)-2-alkoxyimino]acetamido 3[4-alkyl-5-oxo-6-hydroxy-3,4 dihydro 1,2,4-triazin 3-yl]thio methyl cephalosporins ELI LILLY AND COMPANY (US) 1980-04-29 US disclosed
EP-0002605-A1 Cephalosporin compounds and formulations containing them for use in the treatment of bacterial infections and the preparation of the cephalosporin compounds ELI LILLY AND COMPANY (US) 1979-06-27 EP disclosed